Clinical Trial Update: Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing maintenance SUO11248 versus placebo after chemotherapy in patients with advanced urothelial carcinoma (bladder cancer) was terminated,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Drugs mentioned

• SUO11248

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Bladder Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-11-13